NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-167-2010-0-ES-06 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling ES EP 11720697.9 Issued
NCI E-167-2010-0-GB-08 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling GB EP 11720697.9 Issued
NCI E-167-2010-0-IT-09 Peptide-Based Inhibitor Of Interleukin-10 Or Interferon-Gamma Signaling IT EP 11720697.9 Issued
NCI E-040-2009-0-US-04 A Semiconductor For Measuring Biological Interactions US National Stage 13/128,851 8614466 Issued PDF
NIDDK E-129-2010-0-PCT-02 Programmable Self-Assembled Nanostructures Based On Side Chain-Modified PNA For The Multivalent Display Of Ligands PCT PCT PCT/US2011/036090 Expired
NHGRI E-090-2010-0-US-05 METHODS OF DIAGNOSING AND PROGNOSING CANCER SUCH AS MELANOMA AND METHODS OF SELECTING COMPOUNDS TO TREAT MELANOMA. US National Stage 13/055,132 Abandoned
NCATS E-134-2010-0-EP-05 Inhibitors of human 12-Lipoxygenase EP National Stage 11721629.1 Abandoned
NCI E-167-2010-0-PCT-02 Peptide-Based Inhibitor Of Interleukin 10 Or Interferon-Gamma Signaling PCT PCT PCT/US2011/036010 Expired
NCI E-081-2011-0-US-01 Tropolone Compounds For Treating Or Preventing Retroviral Infection US 61/484,779 Abandoned
NIAID E-312-2008-0-US-03 METHOD OF MAKING AN ISOLATED POPULATION OF FOXP3+ REGULATORY T CELLS US National Stage 13/060,043 8951793 Issued PDF
NCI E-150-2007-0-US-05 Compositions And Methods For Treating Pigmentary Conditions and Melanoma US National Stage 13/059,219 8946291 Abandoned PDF
NIDDK E-064-2004-0-US-25 Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment US DIV 13/103,294 8318666 Expired PDF
NIAID E-242-2011-0-US-01 Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Crystal Structures and Deep Sequencing US 61/484,184 Abandoned
NIDDK E-067-2010-0-JP-08 Inverse Agonists And Neutral Antagonists For the TSH Receptor JP National Stage 2013-503984 Abandoned
NIAID E-122-2001-0-US-09 Anti-Arthropod Vector Vaccines,Methods of Selecting and Uses Thereof US CON 13/102,936 8343499 Expired PDF
NCI E-286-2009-0-US-02 Customizable Specimen Evaluation US ORD 13/102,133 Abandoned
NCI E-117-2011-0-US-01 Recombinant Immunotoxin Targeting Mesothelin US 61/483,531 Abandoned
NCI E-024-2009-0-US-04 Gene Signature for Predicting Prognosis Of Patients With Solid Tumors US National Stage 13/127,701 8735082 Issued PDF
NIDCR E-302-2008-0-US-05 Chemoprevention Of Head And Neck Squamous Cell Carcinomas US National Stage 13/059,335 Abandoned
NICHD E-308-2008-0-US-03 Vaccine For Shigella US National Stage 13/059,051 8747863 Abandoned PDF
NIAID E-160-2010-1-PCT-01 Methods of Treating Infection: Inhhibition Of DNA Dependent Protein Kinase (DNT-PK) PCT PCT COMB PCT/US11/34774 Expired
CC E-126-2011-0-US-01 Chemical modification of apolipoprotein mimetic Peptides for the production of therapeutic agents US 61/480,986 Abandoned
NCATS E-041-2010-0-PCT-02 Small Molecule Neuropeptide S Antagonists For The Treatment Of Addictive Disorders, Mood, Anxiety And Sleep Disorders PCT PCT PCT/US2011/034276 Expired
NCATS E-094-2011-0-US-01 Inhibitors Of Human Apurinic/apyrimidinic Endonuclease 1 (APE1) US 61/480,145 Abandoned
NIDA E-230-2007-0-US-03 Unnatural Opioid Enantiomers As Drugs For Treatment Of Pain US National Stage 12/740,688 Abandoned
NCI E-200-2010-0-PCT-02 Therapies Using Zanolimumab To Enhance The Immune Response PCT PCT PCT/US11/034066 Abandoned
NHLBI E-196-1998-2-US-16 Method For Pressure Mediated Selective Delivery of Therapeutic Substances and Cannula US CON 13/094,764 8409166 Abandoned PDF
NCATS E-120-2010-0-JP-06 Activators Of Human Pyruvate Kinase JP National Stage 508139/2013 Pending
NCATS E-120-2010-0-EP-05 Activators Of Human Pyruvate Kinase EP National Stage 11730473.3 Abandoned
NCATS E-120-2010-0-PCT-02 Activators Of Human Pyruvate Kinase PCT PCT PCT/US2011/033852 Expired
NCATS E-120-2010-0-AU-03 Activators Of Human Pyruvate Kinase AU National Stage 2011245441 Abandoned
NCATS E-120-2010-0-CA-04 Activators Of Human Pyruvate Kinase CA National Stage 2797694 Abandoned
NCATS E-326-2008-0-US-07 Activators Of Human Pyruvate Kinase M2 Receptor US CON 13/123,297 8841305 Issued PDF
NCI E-144-2011-0-US-01 Transient Hypoxia Inducers And Their Use US 61/478,465 Abandoned
NIEHS E-180-2011-4-PCT-01 METHOD OF IDENTIFYING AND TREATING A PATIENT HAVING A PREDISPOSITION TO OR AFFLICTED WITH PARKINSON DISEASE PCT PCT COMB PCT/US2011/000702 Expired
NIAID E-102-2010-0-PCT-02 Sound Attenuation Canopy PCT PCT PCT/US2011/033246 Expired
NIDCR E-142-2011-0-US-01 AAV Mediated Exendin-4 Gene Transfer To Salivary Glands To Protect Subjects From Diabetes Or Obesity US 61/477,523 Abandoned
NIDDK E-284-2008-0-US-07 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists US National Stage 13/125,045 8741259 Issued PDF
NCI E-130-2011-0-US-01 Human Monoclonal Antibody Specific for Glypican-3 And Use Thereof US 61/477,020 Abandoned
NCI E-295-2008-0-US-04 Nuclear Factor Kappa B Pathway Inhibitor Composition And Use of Same US National Stage 13/120,044 8729053 Issued PDF
NIAID E-115-2007-0-US-04 Recombinant Human Parainfluenze Type 1 Viruses (HPIV1s) Containing Mutations In Or Deletion Of The C Protein Are Attenuated In African Green Monkeys And In Ciliated Human Airway Epothelial Cells And Are Potential Vaccine Candidates For HPIV1 US National Stage 13/001,710 Abandoned
NIAID E-154-2010-1-EP-02 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines EP National Stage 11769662.5 Issued
NIAID E-154-2010-1-FR-09 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines FR EP 11769662.5 Issued
NIAID E-154-2010-1-DE-06 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines DE EP 11769662.5 Issued
NIAID E-154-2010-1-BE-07 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines BE EP 11769662.5 Issued
NIAID E-154-2010-1-ES-08 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines ES EP 11769662.5 Issued
NIAID E-154-2010-1-IE-11 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines IE EP 11769662.5 Issued
NIAID E-154-2010-1-IT-12 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines IT EP 11769662.5 Issued
NIAID E-154-2010-1-TR-14 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines TR EP 11769662.5 Issued
NIAID E-154-2010-1-GB-10 Chimpanzee Adenoviral Vector-Based Filovirus Vaccines GB EP 11769662.5 Issued